Editors:
- Offers up-to-date information on the diagnosis, treatment, and research surrounding bipolar depression
- Explores basic neurobiological research as well as clinical applications
- Expands on the first edition with new studies on drug treatment
- Primarily aimed at researchers, clinicians, postgraduate students and trainees
Part of the book series: Milestones in Drug Therapy (MDT)
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (15 chapters)
-
Front Matter
-
Bipolar Depression: Clinical Phenotype and Course of Illness
-
Front Matter
-
-
Bipolar Depression: Neurobiology
-
Front Matter
-
-
Acute and Long-term Treatment of Bipolar Depression
-
Front Matter
-
-
Treatment of Bipolar Disorder in Special Populations
-
Front Matter
-
About this book
This book brings together mental health professionals and researchers to offer the most up-to-date information on the diagnosis, treatment, and research surrounding bipolar depression. Its individual chapters provide valuable diagnostic information, allowing clinicians to distinguish between the various mood disorders. Further, they: review the course, outcome, and genetics of this highly heritable condition; offer a thorough overview of the neurobiology of the disorder, including what is known from neuroimaging work; delineate the treatment of bipolar depression in special populations such as children and pregnant women; address suicide, focusing on the need for assessment during both acute and maintenance treatment with interventions appropriate to a patient’s symptoms and history; and cover acute and long-term treatment strategies for bipolar depression, including both traditional and novel therapeutics for the disorder, as well as non-pharmacological treatments.
This second edition reflects significant advances, including an improved understanding of the altered neurobiology of patients suffering from bipolar depression, new information on pathophysiology and genetic findings drawn from diverse studies, and a discussion of the significant strides made towards improved treatment with already available and novel agents.
Editors and Affiliations
-
Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, USA
Carlos A. Zarate Jr.
-
Janssen Pharmaceuticals of Johnson and Johnson, Janssen Research and Development, Titusville, USA
Husseini K. Manji
Bibliographic Information
Book Title: Bipolar Depression: Molecular Neurobiology, Clinical Diagnosis, and Pharmacotherapy
Editors: Carlos A. Zarate Jr., Husseini K. Manji
Series Title: Milestones in Drug Therapy
DOI: https://doi.org/10.1007/978-3-319-31689-5
Publisher: Springer Cham
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Springer International Publishing Switzerland (outside the USA) 2016
Hardcover ISBN: 978-3-319-31687-1Published: 06 February 2017
Softcover ISBN: 978-3-319-81096-6Published: 12 July 2018
eBook ISBN: 978-3-319-31689-5Published: 28 January 2017
Series ISSN: 2296-6056
Series E-ISSN: 2296-6064
Edition Number: 2
Number of Pages: X, 371
Number of Illustrations: 2 b/w illustrations, 10 illustrations in colour
Topics: Pharmacology/Toxicology, Psychopharmacology, Neurosciences